| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/25/2006 | CN1724068A Method for preparing intensified inactivated cholera fowl vaccine |
| 01/25/2006 | CN1724063A Method for producing turmeric stable prepn. |
| 01/25/2006 | CN1724062A Medicine for treating tuberculosis, and its prodn. method |
| 01/25/2006 | CN1724058A Disinfectant liquid for treating hand/foot tinea |
| 01/25/2006 | CN1724037A Traditional Chinese medicinal oral liquor for treating liver trouble |
| 01/25/2006 | CN1724024A Traditional Chinese medicine for treating hepatitis B, and its prepn. method |
| 01/25/2006 | CN1724007A Medicine contg. zinc, honeysuckle, Radix scutellariae and forsynthia fruit |
| 01/25/2006 | CN1724006A Method for producing granular medicine contg. honeysuckle, Radix scutellariae and foysythia fruit |
| 01/25/2006 | CN1723985A Traditional Chinese medicine for treating mumps |
| 01/25/2006 | CN1723965A Method and use for preparing medicine extracted myrobalan for treating diseases infected by bacteria or virus |
| 01/25/2006 | CN1723952A External use traditional Chinese medicinal preparation for treating ringworm of the nails |
| 01/25/2006 | CN1723922A Medicine for treating viral influenza, and its prepn. method |
| 01/25/2006 | CN1723915A Nanometer dental caries prevention and antibiotic material, and its prepn. method and toothpaste containing the material |
| 01/25/2006 | CN1723911A Amphotericin B slow-releasing microsphere, and its prepn. method |
| 01/25/2006 | CN1723910A Injectable azithromycin freeze-dried powder, and its prepn. method |
| 01/25/2006 | CN1723908A Gelatin micro-particles carried with dichloromethylene diphosphonate, and its prepn. method |
| 01/25/2006 | CN1723906A Cucurbitacine liposome and its prepn. method |
| 01/25/2006 | CN1723905A Cefdinir oral disintegration tablet, and its prepn. method |
| 01/25/2006 | CN1723903A Matrix metalloproteinase and tumor necrosis factor inhibitors |
| 01/25/2006 | CN1723902A 'Ennoxacin' micro-capsule, and its prepn. method |
| 01/25/2006 | CN1723901A Fleroxacin lactate dispersion tablet, and its prepn. method |
| 01/25/2006 | CN1723898A Fibranine gel, and its prepn. method |
| 01/25/2006 | CN1723891A Wrapped Rifamycin sodium powder-injection and its prepn. method |
| 01/25/2006 | CN1723881A Compounding medicine contg. coenzyme O30 for treating dermatosis, and its prepn. method |
| 01/25/2006 | CN1238499C Antibody against AIDS virus O and its production cell series and uses |
| 01/25/2006 | CN1238378C An antibiotic peptide and its coded sequence and use |
| 01/25/2006 | CN1238377C Acidic antibacterial peptides and gene as well as its application in pharmacy |
| 01/25/2006 | CN1238364C Novel erythromycin derivatives, method for preparing them and their use as medicine |
| 01/25/2006 | CN1238357C Hypoxylonin and its preparation method and application |
| 01/25/2006 | CN1238353C Amino acid ester containing azole antifungal agent |
| 01/25/2006 | CN1238054C Biotechnological formulation for suppressing and killing helicobacter pylori, its preparation and its uses |
| 01/25/2006 | CN1238053C Medicine composition containing alfa-interferon , lamivudine and adefovir |
| 01/25/2006 | CN1238037C Medicine for treating pneumonia and SARS |
| 01/25/2006 | CN1238035C Medicine for treating tuberculosis and its preparing process |
| 01/25/2006 | CN1238031C Oral liquid for treating virus cold and throat disease and its preparation technology |
| 01/25/2006 | CN1238013C Myocarditis treating Chinese medicine preparation |
| 01/25/2006 | CN1238011C Medicine for preventing and treating fowl pos disease |
| 01/25/2006 | CN1237992C Chinese medicine for treating tuberculosis |
| 01/25/2006 | CN1237989C Drug for upper respiratory tract infection |
| 01/25/2006 | CN1237988C Medicine for treating epidemic parotitis |
| 01/25/2006 | CN1237986C Medicine for treating chickenpest |
| 01/25/2006 | CN1237983C Compound dryopteris rhizome aspirin tablet |
| 01/25/2006 | CN1237976C Bite spiramycin and its use in anti inflammatory disease |
| 01/25/2006 | CN1237974C Ursolic acid dripping pills and its preparation process |
| 01/25/2006 | CN1237963C Garlimax concentrated solution for intravenous injection after composite solvent dilution |
| 01/25/2006 | CN1237961C Use of diphenyl ethylene-like compounds in preparing medicaments for treating and preventing diabetes or diseases associated with retrovirus |
| 01/25/2006 | CN1237957C Hypocrellin liposome solid powder preparaton and producing method |
| 01/24/2006 | US6989447 Compounds |
| 01/24/2006 | US6989435 Compounds and methods to inhibit or augment an inflammatory response |
| 01/24/2006 | US6989401 Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products |
| 01/24/2006 | US6989396 Anticancer agents; modulating glycoprotein |
| 01/24/2006 | US6989393 Ccr5 modulators benzimidazoles or benzotriazoles |
| 01/24/2006 | US6989389 Immunomodulators; tetrahydroimidazo[4,5-c]quinoline-4-amine-1-(alkynyloxyalkyl) derivatives; induce cytokines biosynthesis; antitumor agents, viral diseases |
| 01/24/2006 | US6989385 Pyrazole compounds useful as protein kinase inhibitors |
| 01/24/2006 | US6989384 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 01/24/2006 | US6989381 Containing s cyclodextrin compound in a concentration sufficient to maintain the drug in solution at such a drug concentration. |
| 01/24/2006 | US6989372 medicaments intended to increase the intracellular and/or extracellular level of glutathione (GSH); for example, N-(N-Acetyl-L-cysteinyl)-S-acetylcysteamine; hiv treatment |
| 01/24/2006 | US6989260 Gene expression inhibition; for treatment of inflammatory, neurological, cardiovascular, and neoplastic tisssue growth disorders |
| 01/24/2006 | US6989255 for protection against staphylococcus infection; fusion proteins |
| 01/24/2006 | US6989159 Pharmaceutical compositions containing lithium carbonate |
| 01/24/2006 | US6989156 Forming a free- standing powder comprising at least one antimicrobial metal with atomic disorder; and injecting the free-standing powder in therapeutically effective amounts to the tissue which is to be treated |
| 01/24/2006 | US6989146 Stress proteins and peptides and methods of use thereof |
| 01/24/2006 | US6988619 Medicinal product package for eradication therapy |
| 01/24/2006 | CA2368431C Melanocortin receptor ligands |
| 01/24/2006 | CA2351315C Humanized antibody specific for surface antigen pre-s1 of hbv and preparation method thereof |
| 01/24/2006 | CA2339353C Fast dissolving orally consumable films |
| 01/24/2006 | CA2292984C Ccr5 modulators |
| 01/24/2006 | CA2100228C Phospholipid derivatives |
| 01/23/2006 | CA2513024A1 Vibrio cholerae lps detoxified derivatives and immunogenic compositions containing them |
| 01/23/2006 | CA2475736A1 Vibrio cholerae lps detoxified derivatives and immunogenic compositions containing them |
| 01/21/2006 | CA2512515A1 Super-antigen fusion proteins and the use thereof |
| 01/19/2006 | WO2006006720A1 METHOD OF CULTURING ϜδT CELLS, ϜδT CELLS AND REMEDY/PREVENTIVE |
| 01/19/2006 | WO2006005268A2 Pharmaceutical composition containing polypeptide fragments of serralysins |
| 01/19/2006 | US20060014947 Levofloxicin prepared by reduction of an entantiomorph of 2,3,4 trihalo,N-(1-alkoxycarbonylethyl-)aniline by a metal borohydride in an aprotic solvent and alcohol; reacting the product with a 2,2-dialkoxycarbonyl-ethyl halide; cyclization using a base and phase transfer agents; optical purity;efficiency |
| 01/19/2006 | US20060014937 Humanized antibody against S-surface antigen of hepatitis B virus |
| 01/19/2006 | US20060014930 Synthetic or natural peptides binding protein phosphatase 2A, identification method and uses |
| 01/19/2006 | US20060014825 Novel k99-5278 substance and a process for producing the same |
| 01/19/2006 | US20060014803 Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 01/19/2006 | US20060014780 Nicotinamide derivatives useful as PDE4 inhibitors |
| 01/19/2006 | US20060014760 Compounds and methods of use to treat infectious diseases |
| 01/19/2006 | US20060014750 Pharmaceutical compositions for the treatment of CNS and other disorders |
| 01/19/2006 | US20060014749 (R)-2-{4-[(1H-Indol-2-ylmethyl)-amino]-piperidin-1-yl}-1-(6-methoxyquinolin-4-yl)-ethanol; effective against both gramnegative and grampositive bacteria |
| 01/19/2006 | US20060014748 2-NH-heteroarylimidazoles with antibacterial activity |
| 01/19/2006 | US20060014743 Methods of preventing bacterial infections with florfenicol-type antibiotics |
| 01/19/2006 | US20060014730 Ansamycin formulations and methods for producing and using same |
| 01/19/2006 | US20060014725 6-(1-benzyl-3-pentyl-1H-indol-2-yl)-1-bromo-2-naphthyl 1H-tetraazol-5-ylmethyl ether; useful in treating stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders |
| 01/19/2006 | US20060014718 oversulfation of epiK-N sulfate to obtain an epiK5-amine-O-oversulfate with very high sulfation degree which by subsequent N-sulfation provides new epiK5-N,O-oversulfate-derivatives; free of activity on the coagulation parameters and useful in the cosmetic or pharmaceutical field |
| 01/19/2006 | US20060014702 Antimicrobial agent |
| 01/19/2006 | US20060014701 Novel amide derivatives as growth hormone secretagogues |
| 01/19/2006 | US20060014672 Tumor specific oligosaccharide epitopes and use thereof |
| 01/19/2006 | US20060014139 Which comprises three N-helices and at least two, but not three, of the three C-helices of the trimer-of-hairpin structure of HIV gp41; inhibits infection of cells; drug screening; gene therapy |
| 01/19/2006 | US20060013906 Anti-helicobacter activity of celery seed extract |
| 01/19/2006 | US20060013895 Use of a composition and a cleaning tablet containing said composition for disinfecting purposes |
| 01/19/2006 | US20060013877 Hybrid of itraconazole, cyclosporine or carvedilol with a layered silicate and a process for preparing the same |
| 01/19/2006 | US20060013869 Electrospun amorphous pharmaceutical compositions |
| 01/19/2006 | DE202005014460U1 Tablet, useful for treating and/or preventing infections caused by influenza, comprises a plant extract of the genus Cistus |
| 01/19/2006 | DE202005014459U1 Aerosol, useful for treating and/or preventing infections caused by influenza, comprises a plant extract of the genus Cistus |
| 01/19/2006 | CA2573927A1 Porphyrin linked metronidazole against gum disease: porphyromonas gingivalis |
| 01/19/2006 | CA2572984A1 A pharmaceutical composition containing polypeptide fragments of the serralysins |
| 01/19/2006 | CA2572881A1 Antigen binding proteins directed against scavenger receptor b1 that inhibit hcv replication |